PotentandselectiveLXRinverseagonist(IC50valuesare43and214nMforLXRβandLXRα,respectively).SelectivelyinhibitsliverLXRoverperipheralLXR.ExhibitsselectivityforLXRoverapanelof20othernuclearreceptors,includingFXR.Reduceshepaticsteatosisinobesemice.
| M.Wt | 595.73 |
| Formula | C31H33NO7S2 |
| Storage | Storeat+4°C |
| Purity | ≥98%(HPLC) |
| CASNumber | 1416153-62-2 |
| PubChemID | 71478195 |
| InChIKey | HDZWHJYZJWLTAG-UHFFFAOYSA-N |
| Smiles | CCOC(C1=CC=C(O1)CN(S(=O)(C2=C(C=C(C=C2C)C)C)=O)CC3=CC=C(C4=CC(S(C)(=O)=O)=CC=C4)C=C3)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 59.57 | 100 |
Thefollowingdataisbasedontheproductmolecularweight595.73.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 1.68mL | 8.39mL | 16.79mL |
| 5mM | 0.34mL | 1.68mL | 3.36mL |
| 10mM | 0.17mL | 0.84mL | 1.68mL |
| 50mM | 0.03mL | 0.17mL | 0.34mL |



